Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Sees Large Increase in Short Interest

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) saw a large increase in short interest in October. As of October 15th, there was short interest totalling 56,500 shares, an increase of 228.5% from the September 30th total of 17,200 shares. Based on an average trading volume of 58,800 shares, the short-interest ratio is currently 1.0 days.

Fresenius SE & Co. KGaA Stock Down 0.3 %

OTCMKTS FSNUY traded down $0.03 during trading on Friday, reaching $9.11. 25,057 shares of the company’s stock traded hands, compared to its average volume of 27,428. Fresenius SE & Co. KGaA has a 12-month low of $6.33 and a 12-month high of $9.78. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.29 and a quick ratio of 1.00. The firm has a market cap of $20.34 billion, a price-to-earnings ratio of 12.24 and a beta of 1.05. The company’s 50 day simple moving average is $9.28 and its two-hundred day simple moving average is $8.39.

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) last issued its quarterly earnings data on Wednesday, July 31st. The company reported $0.22 earnings per share for the quarter. The company had revenue of $5.83 billion for the quarter. As a group, sell-side analysts forecast that Fresenius SE & Co. KGaA will post 0.84 EPS for the current fiscal year.

Fresenius SE & Co. KGaA Company Profile

Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.